ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed
Zhichao Xu
Matched on ORCID iD 0000-0003-1753-5602; OpenAlex author ID A5065968878. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 3
- Circ_0018909 knockdown inhibits the development of pancreatic cancer via the miR-545-3p/FASN axis and reduces macrophage polarization to M2. Last author DOI 10.1002/jbt.23293↗
- Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer. First author DOI 10.1016/j.pan.2018.08.009↗
- MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway. Co-author DOI 10.1177/1010428317711324↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jing Xu · 3 shared papers, 2017–2023 · strength 0.42
- Paper Circ_0018909 knockdown inhibits the development of pancreatic cancer via the miR-545-3p/FASN axis and reduces macrophag… DOI 10.1002/jbt.23293↗
- Paper Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition i… DOI 10.1016/j.pan.2018.08.009↗
- Paper MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wn… DOI 10.1177/1010428317711324↗
- Yinxue Song · 2 shared papers, 2018–2023 · strength 0.33
- Paper Circ_0018909 knockdown inhibits the development of pancreatic cancer via the miR-545-3p/FASN axis and reduces macrophag… DOI 10.1002/jbt.23293↗
- Paper Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition i… DOI 10.1016/j.pan.2018.08.009↗
- Chunli Li · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.